Company Overview - Synopsys, Inc. is a technology company specializing in the design and verification of silicon chips for the semiconductor design and manufacturing industry [3]. Allegations and Financial Impact - On September 9, 2025, Synopsys reported missing its prior guidance on earnings per share and revenue for the third quarter of 2025, attributing the disappointing results to "new export restrictions" and disruptions with a major foundry customer [4]. - The company also cited "certain roadmap and resource decisions that did not yield their intended results" as contributing factors to the negative financial performance [4]. Stock Market Reaction - Following the announcement of the missed guidance, Synopsys' stock price fell by $216.59 per share, or 35.8%, closing at $387.78 per share on September 10, 2025 [5].

Core Insights - Block & Leviton LLP is investigating Barnes & Noble Education, Inc. for potential securities law violations following a significant drop in stock price due to accounting errors [1][2][5] Financial Reporting Issues - On July 21, 2025, Barnes & Noble's stock price fell over 20% after the company disclosed delays in filing its annual report, attributed to accounting errors [2] - An internal investigation indicated that the company may have overstated accounts receivable by up to $23 million, raising concerns about the accuracy of its financial reporting [2] - The company expects to identify at least one material weakness in internal controls, suggesting ineffective disclosure procedures for multiple fiscal years [2] Regulatory Filings - On September 12, 2025, Barnes & Noble announced a delay in filing its Form 10-Q for the period ending August 2, 2025, primarily due to the ongoing internal investigation [3] Investor Eligibility - Any investor who purchased Barnes & Noble Education, Inc. common stock and experienced a decline in share value may be eligible to seek recovery of losses [4] Legal Actions - Block & Leviton is actively investigating whether Barnes & Noble committed securities law violations and may file actions to recover losses for affected investors [5] Whistleblower Information - Individuals with non-public information about Barnes & Noble are encouraged to assist in the investigation or report to the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [7]

Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [1]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [1]. - Defendants allegedly downplayed inefficiencies that arose during the integration process and assured investors of their commitment to resolving these issues quickly [1]. - Shareholders are encouraged to register for the class action and can do so without any cost or obligation [2]. Group 2: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Flywire Corporation regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's revenue growth and business impacts from permit and visa restrictions [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 28, 2024, to February 25, 2025, Flywire's revenue growth was overstated [3]. - It is claimed that the negative impact of permit- and visa-related restrictions on Flywire's business was understated [3]. - As a result, the public statements made by the defendants were materially false and misleading throughout the relevant time [3]. Group 2: Class Action Details - Shareholders who purchased shares of Flywire during the specified class period are encouraged to contact the Gross Law Firm for potential lead plaintiff appointment [1][4]. - The deadline for shareholders to register for the class action is September 23, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Group 3: Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and engage in good corporate citizenship [5].

Core Viewpoint - The Schall Law Firm is investigating claims against CTO Realty Growth, Inc. for potential violations of securities laws, particularly regarding misleading statements about the sustainability of its dividend [1][2]. Group 1: Investigation Details - The investigation centers on whether CTO Realty Growth issued false or misleading statements and failed to disclose important information to investors [2]. - A report by Wolfpack Research, published on June 25, 2025, alleges that CTO misled investors about its dividend sustainability, leading to a share price decline of over 5.4% [2]. Group 2: Legal Representation - The Schall Law Firm offers free consultations for shareholders who believe they have suffered losses due to the alleged misleading information from CTO [3].

Group 1 - Rowley Law PLLC is investigating potential securities law violations by Verint and its board of directors regarding the proposed acquisition by Thoma Bravo [1] - The acquisition deal values Verint at approximately $2 billion, with stockholders set to receive $20.50 for each share they hold [1] - The transaction is expected to close before the end of the fiscal year [1] Group 2 - Stockholders interested in the investigation can obtain additional information through Rowley Law PLLC's website or by contacting the firm directly [2] - Rowley Law PLLC represents shareholders in class actions and derivative lawsuits in complex corporate litigation [3]

Core Viewpoint - Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) is facing a class action lawsuit due to allegations of misleading statements regarding its business model and growth prospects during the pandemic [3][5]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from January 14, 2021, to June 5, 2025 [3]. - Allegations include that Petco's pandemic-related growth was unsustainable and that its business model, which focuses on premium pet food, was overstated [3]. - The company is accused of downplaying the severity of issues affecting its business and overstating its ability to achieve sustainable, profitable growth [3]. Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by August 29, 2025 [4]. - Registration allows shareholders to receive updates on the case and does not incur any costs or obligations [4]. Law Firm Information - The Gross Law Firm is leading the class action and is recognized for protecting investors' rights against deceit and fraud [5]. - The firm aims to hold companies accountable for misleading statements that inflate stock prices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Sarepta Therapeutics, Inc. regarding a class action lawsuit related to misleading statements about the safety and efficacy of its gene therapy product, ELEVIDYS [1][3]. Summary by Relevant Sections Class Action Details - The class period for the lawsuit is from June 22, 2023, to June 24, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to contact the firm for potential lead plaintiff appointment, although this is not required for recovery [1][4]. Allegations Against Sarepta Therapeutics - The complaint alleges that Sarepta Therapeutics made materially false and/or misleading statements regarding ELEVIDYS, a gene therapy for Duchenne muscular dystrophy [3]. - Specific allegations include: - ELEVIDYS poses significant safety risks to patients [3]. - The trial protocols failed to detect severe side effects [3]. - Adverse events from ELEVIDYS treatment could lead to halting recruitment and dosing in trials, attracting regulatory scrutiny [3]. - The misleading statements resulted in a lack of reasonable basis for the company's positive outlook on the therapy [3]. Next Steps for Shareholders - Shareholders are advised to register for the class action by August 25, 2025, to participate in the case [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software [4]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Schall Law Firm is investigating Telix Pharmaceuticals Limited for potential violations of securities laws related to misleading statements and undisclosed information regarding its prostate cancer therapeutic candidates [1][2]. Group 1: Investigation Details - The investigation centers on whether Telix issued false or misleading statements and failed to disclose relevant information to investors [2]. - On July 22, 2025, Telix announced it received a subpoena from the SEC concerning its disclosures about the development of its prostate cancer therapeutic candidates [2]. - Following the SEC subpoena announcement, Telix's American Depositary Receipts (ADRs) experienced a decline of over 10.4% the next day [2]. Group 2: Legal Representation - The Schall Law Firm is representing investors globally and specializes in securities class action lawsuits and shareholder rights litigation [3]. - Shareholders who have suffered losses are encouraged to contact the Schall Law Firm for a free discussion of their rights [3].

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of NorthWestern Energy by Black Hills Corp, which will result in NorthWestern Energy stockholders receiving 0.98 shares of Black Hills common stock for each share they hold [1] Group 1 - The acquisition is expected to close in the latter half of 2026 [1] - NorthWestern Energy stockholders are projected to own approximately 44% of the combined company post-acquisition [1]